Key evaluationQuestionsGroup 5

Futureopportunities

KEQ3. To what extent do the actions in the Plan need to be adapted/changed?

Key messages

  • The Plan remains strategically sound and must now shift from establishing direction to delivering measurable impact

    Stakeholders broadly endorsed the Plan's objectives and priorities, identifying no need for fundamental redesign; they consistently called for a stronger focus on operationalisation, accountability, and implementation capacity as the Plan enters its next phase.

  • Immediate priorities centre on strengthening evaluation, prioritisation, governance, and accountability mechanisms

    Stakeholders emphasised the need to define success measures now, clarify roles and responsibilities, strengthen delivery focus, and consider a broader mix of policy levers to drive more consistent implementation across the system.

  • Building system capability requires sustained investment in data infrastructure, implementation supports, and workforce

    These foundational enablers, consistently identified as both constraints and opportunities, are prerequisites for scaling and sustaining implementation over the Plan's remaining horizon.

  • Deepening impact requires moving equity and consumer voice from principle to practice

    Stakeholders called for equity to be operationalised as a measurable and resourced component of system performance, with lived experience more deeply embedded more deeply in care design, service delivery, and evaluation – building on the foundations established at the policy and advisory level.

  • The Plan must remain adaptive and responsive over its 10-year horizon

    The pace of change in cancer treatment, genomics, and digital health requires built-in mechanisms for horizon scanning, periodic review, and adaptive planning to ensure the Plan remains current, credible, and fit for purpose.

Opportunities to strengthen implementation and delivery

The next phase is about moving from strategic alignment to focused delivery, stronger capability and measurable, equitable impact.

Define what success looks like

Why it matters:

Stakeholders want clearer measures of progress before the 5-year milestone.

What it enables:

Shared indicators, baselines and evidence to demonstrate impact.

Focus effort where it matters most

Why it matters:

Activity is widespread, but sharper prioritisation is needed to accelerate outcomes.

What it enables:

A clearer delivery focus on high-impact actions.

Clarify who does what

Why it matters:

Shared responsibility can diffuse accountability in a complex federated system.

What it enables:

Better coordination, less duplication and clearer roles across the system.

Use stronger policy levers

Why it matters:

Voluntary alignment has built momentum, but may not be enough to drive consistent uptake.

What it enables:

Funding, reporting and accountability mechanisms that support delivery.

Build better data systems

Why it matters:

Current data are not yet sufficient to measure reach, scale or impact.

What it enables:

Timelier, linked and usable data to track progress and support learning.

Support implementation in practice

Why it matters:

Frameworks need practical tools, guidance and knowledge-sharing to be used at the frontline.

What it enables:

Translation of national frameworks into consistent local practice.

Strengthen workforce capability

Why it matters:

Workforce and organisational capacity are key constraints on delivery.

What it enables:

A more capable, culturally safe and sustainable cancer workforce.

Make equity measurable and resourced

Why it matters:

Equity has been elevated, but is not yet consistently embedded across implementation.

What it enables:

Shared accountability for equitable outcomes, including Aboriginal and Torres Strait Islander cancer outcomes.

Embed consumer voice

Why it matters:

Consumers report limited visible change and need stronger involvement in implementation.

What it enables:

Care design, service delivery and evaluation that better reflect lived experience.

Keep the Plan adaptive

Why it matters:

Cancer control is changing rapidly through genomics, digital health and emerging evidence.

What it enables:

A living framework that can respond to new opportunities and risks.

Nature and extent of change required

Across consultation and survey data, stakeholders were clear that the Plan does not require fundamental redesign. Its objectives, priorities, and strategic direction were broadly endorsed, and there was no substantive call to change the Plan’s actions at this stage of implementation. In this sense, KEQ3 – which asks the extent to which actions need to be adapted or changed – is answered primarily in the negative: the Plan itself is not what needs to change. Rather, stakeholders consistently emphasised the need to strengthen implementation, measurement, and system coordination as the Plan transitions from early establishment to sustained delivery and impact. The forward-looking framing of this section as future opportunities reflects this interpretation.

The ten areas for change and strengthening presented below were identified by stakeholders through consultation and survey data, and grouped through the analysis process into three clusters based on their primary focus and implementation timeframe:

  • Immediate priorities: Strengthen the foundations for delivery, accountability, and coordination in the next phase of implementation
  • System capability: Strengthening infrastructure, workforce, and practical supports needed to enable, scale, and sustain implementation over time
  • Deepening impact: Ensuring the Plan's benefits are equitably experienced and that the Plan remains responsive, credible, and fit for purpose over its 10-year horizon.

While all ten areas are interconnected and mutually reinforcing, the grouping is intended to support prioritisation and broad sequencing of effort rather than imply that any area is optional or lesser importance. Together, these opportunities reflect a shift from establishing national direction to strengthening the system architecture, capability, and mechanisms needed to deliver measurable and equitable impact.

Nature and extent of change required

Across consultation and survey data, stakeholders were clear that the Plan does not require fundamental redesign. Its objectives, priorities, and strategic direction were broadly endorsed, and there was no substantive call to change the Plan’s actions at this stage of implementation. In this sense, KEQ3 – which asks the extent to which actions need to be adapted or changed – is answered primarily in the negative: the Plan itself is not what needs to change. Rather, stakeholders consistently emphasised the need to strengthen implementation, measurement, and system coordination as the Plan transitions from early establishment to sustained delivery and impact. The forward-looking framing of this section as future opportunities reflects this interpretation.

The ten areas for change and strengthening presented below were identified by stakeholders through consultation and survey data, and grouped through the analysis process into three clusters based on their primary focus and implementation timeframe:

  • Immediate priorities: Strengthen the foundations for delivery, accountability, and coordination in the next phase of implementation
  • System capability: Strengthening infrastructure, workforce, and practical supports needed to enable, scale, and sustain implementation over time
  • Deepening impact: Ensuring the Plan's benefits are equitably experienced and that the Plan remains responsive, credible, and fit for purpose over its 10-year horizon.

While all ten areas are interconnected and mutually reinforcing, the grouping is intended to support prioritisation and broad sequencing of effort rather than imply that any area is optional or lesser importance. Together, these opportunities reflect a shift from establishing national direction to strengthening the system architecture, capability, and mechanisms needed to deliver measurable and equitable impact.

Immediate priorities

Stakeholders consistently reported uncertainty about how success will be defined, measured, and demonstrated over time, and emphasised the need for honest, realistic, and clearly defined success measures and the establishment of robust evaluation architecture ahead of key milestones. Perspectives on what meaningful success looks like at the 5- and 10-year horizons spanned survival and incidence, equity outcomes, patient experience, data infrastructure, and First Nations leadership — with stakeholders clear that the Plan’s success will ultimately be judged by visible change in the experiences and outcomes of people affected by cancer.

The Plan requires a shift from broad aspirational goals to a clearly defined measurement framework — with indicators, baselines, and data collection established now to strengthen accountability and provide the sector with confidence in how long-term impact will be assessed.

One of my concerns is that because the plan and the evaluation doesn't seem to include specific measures, so every service is going to define their own, and then in terms of how you evaluate the overall impact, it is difficult.
Cancer sector stakeholder in consultation
One of my concerns is that because the plan and the evaluation doesn't seem to include specific measures, so every service is going to define their own, and then in terms of how you evaluate the overall impact, it is difficult.
Cancer sector stakeholder in consultation
Any program that's being funded...should have a really robust monitoring evaluation framework that has been developed and implemented from the outset.
Aboriginal and Torres Strait Islander stakeholder in consultation
Equity is increasingly becoming part of the conversation and that's probably success as well. I think we still do need to have things like survival and incidence as being important measures of success.
Cancer sector stakeholder in consultation
To see outcomes of improved equity would be...you know that doesn't happen overnight, but by 10 years...clearly we'd all be pretty devastated if we haven't turned around outcomes for First Nations people with cancer by that 10 years, that would be devastating if that were to occur.
Cancer sector stakeholder in consultation
It's about ensuring that in the 5 to 10 years from now we have a growing established cohort of mob in leadership positions.
Aboriginal and Torres Strait Islander stakeholder in consultation

Strengthen evaluation and clarify success measures

Stakeholders consistently reported uncertainty about how success will be defined, measured, and demonstrated over time, and emphasised the need for honest, realistic, and clearly defined success measures and the establishment of robust evaluation architecture ahead of key milestones. Perspectives on what meaningful success looks like at the 5- and 10-year horizons spanned survival and incidence, equity outcomes, patient experience, data infrastructure, and First Nations leadership — with stakeholders clear that the Plan’s success will ultimately be judged by visible change in the experiences and outcomes of people affected by cancer.

The Plan requires a shift from broad aspirational goals to a clearly defined measurement framework — with indicators, baselines, and data collection established now to strengthen accountability and provide the sector with confidence in how long-term impact will be assessed.

One of my concerns is that because the plan and the evaluation doesn't seem to include specific measures, so every service is going to define their own, and then in terms of how you evaluate the overall impact, it is difficult.
Cancer sector stakeholder in consultation
One of my concerns is that because the plan and the evaluation doesn't seem to include specific measures, so every service is going to define their own, and then in terms of how you evaluate the overall impact, it is difficult.
Cancer sector stakeholder in consultation
Any program that's being funded...should have a really robust monitoring evaluation framework that has been developed and implemented from the outset.
Aboriginal and Torres Strait Islander stakeholder in consultation
Equity is increasingly becoming part of the conversation and that's probably success as well. I think we still do need to have things like survival and incidence as being important measures of success.
Cancer sector stakeholder in consultation
To see outcomes of improved equity would be...you know that doesn't happen overnight, but by 10 years...clearly we'd all be pretty devastated if we haven't turned around outcomes for First Nations people with cancer by that 10 years, that would be devastating if that were to occur.
Cancer sector stakeholder in consultation
It's about ensuring that in the 5 to 10 years from now we have a growing established cohort of mob in leadership positions.
Aboriginal and Torres Strait Islander stakeholder in consultation

Strengthen implementation focus and prioritisation

While activity is underway across multiple domains, stakeholders identified a need for stronger prioritisation and delivery focus, clearer ordering of effort, and greater emphasis on high-impact actions, with consumers in particular emphasising urgency and the need for faster, more visible progress. Stakeholders highlighted the importance of moving implementation from broad activity to more targeted, measurable delivery, with specific dates, accountabilities, and expectations attached to actions, supported by clearer accountability mechanisms to ensure actions are monitored and acted upon rather than simply reported.

Stakeholders also emphasised that long-term impact, rather than activity, should be the measure of success. Recognising interdependencies across actions will also be important, as progress in some areas, such as data infrastructure and workforce capacity, enables and supports delivery in others.

The Plan is ambitious, but cancer patients don't have time.
Consumer (person affected by cancer) in consultation
The Plan is ambitious, but cancer patients don't have time.
Consumer (person affected by cancer) in consultation
The next phase is execution. The opportunity now is to establish a clear implementation framework that moves the Plan from strategy into coordinated delivery.
Cancer sector stakeholder in survey
All the things in the Plan are very reasonable, but I have to be candid and say they are also by their nature extremely general, and there's not that much in there that I can sit down and say to people who need to write a cheque for me: this is something we need to deliver by this date, or we're going to look bad.
Jurisdictional stakeholder in consultation
We want action, but we needed to plan through that action a bit more strategically — I feel like in two years we're going to deliver these things. I feel like we're sort of ticking the boxes, but I'm really interested in what's the long-term impact.
Aboriginal and Torres Strait Islander stakeholder in consultation
I've seen a lot of frameworks. What matters is whether they actually change care.
Consumer (person affected by cancer) in consultation

Clarify roles and responsibilities

Stakeholders consistently identified unclear roles, responsibilities, and funding arrangements across Commonwealth, state and territory, and sector initiatives, including limited visibility of who is responsible for specific implementation activities and partnerships. Stakeholders also noted overlap and fragmentation between the Plan, the NACCHO Aboriginal and Torres Strait Islander Cancer Plan, and jurisdictional strategies.

Stakeholders identified opportunities to strengthen governance clarity to reduce duplication and support more coherent implementation across the cancer system. Suggested approaches included developing a system map of the cancer ecosystem - clarifying roles, responsibilities, and accountabilities - alongside stronger communication and coordination mechanisms across governments and the broader sector regarding progress and delivery. Stakeholders noted that clearer articulation of roles would also help organisations and individuals identify where they sit within the system and understand their potential contribution within their own sphere of influence, supporting broader and more active engagement with implementation across the sector.

When the Plan is everyone's responsibility, it becomes no-one's.
Jurisdictional stakeholder in consultation
When the Plan is everyone's responsibility, it becomes no-one's.
Jurisdictional stakeholder in consultation
Confusion about who does what — Commonwealth versus state versus Cancer Australia — role ambiguity, especially for newer people in the sector. A simple national 'who does what' map would help.
Jurisdictional stakeholder in consultation
The missing piece for Queensland has been aligning the state direction to the Commonwealth direction and using that as a framework downstream to hospitals and health services.
Jurisdictional stakeholder in consultation
There just needs to be a clear articulation in terms of roles and responsibilities, particularly identifying how it might work locally as opposed to nationally. There seems to be a bit of fragmentation in terms of information sharing and understanding how those roles can best be identified.
Aboriginal and Torres Strait Islander stakeholder in consultation
Given it's a collaborative work plan essentially for the sector, it would be good to know who's working on what.
Cancer sector stakeholder in consultation

Consider a broader mix of policy levers and accountability mechanisms

The Plan operates as a voluntary, non-binding framework, relying on coordinated action and sector alignment rather than regulatory or legislative mechanisms. Stakeholders highlighted the opportunity to consider a broader mix of policy levers - including funding agreements, accreditation standards, reporting requirements, and other accountability mechanisms beyond non-binding strategy and guidance - to create clearer expectations for delivery and support more consistent and sustainable implementation over time. These levers represent foundational governance and accountability settings that could strengthen implementation consistency over time.

There is a clear opportunity to explore how the Plan’s objectives can be more explicitly embedded across government agendas more broadly — including through cross-portfolio policy alignment, intergovernmental agreements, and national reform processes — to complement and strengthen existing agendas and deepen the Plan's influence across the system.

The Plan is not legislatively binding and that creates real challenges — there's no mechanism to require anyone to do anything.
Cancer sector stakeholder in consultation
The Plan is not legislatively binding and that creates real challenges — there's no mechanism to require anyone to do anything.
Cancer sector stakeholder in consultation
Commonwealth funding agreements are probably the most powerful lever available — if you want to drive change, that's where you'd start.
Commonwealth stakeholder in consultation
I think there needs to be some way to make the OCPs more enforceable — at the moment they're just guidelines and people can choose to follow them or not. There needs to be some mechanism to drive uptake.
Cancer sector stakeholder in consultation
The big question is whether we can use accreditation, hospital reporting, or funding agreements to drive uptake of the Plan's priorities — because at the moment it's all voluntary.
Cancer sector stakeholder in consultation
If you want cultural safety to actually happen, it needs to be in contracts, in accreditation standards, in KPIs — not just in a framework.
Aboriginal and Torres Strait Islander stakeholder in consultation

System capability

Data and measurement were consistently identified as both a core system constraint (System-level barriers - Implementation barriers and enablers (KEQ3)) and a future opportunity. Stakeholders highlighted that limitations in data linkage, accessibility, and comparability constrain the ability to monitor progress, demonstrate impact, close equity gaps, and support continuous improvement across the cancer system.

Opportunities identified by stakeholders included strengthening national data linkage and integration, further developing and operationalising the Data Framework (including associated infrastructure investment), and improving the timeliness, accessibility, and usability of data for decision-making. Strengthened data systems were described as foundational to monitoring, evaluation, accountability, and system-wide learning.

We need data that drives change, not just reporting.
Cancer sector stakeholder in survey
We need data that drives change, not just reporting.
Cancer sector stakeholder in survey
The number one is shared data. Once someone solves that — national PROMs and PREMs, a single digit patient record — that's where I think we're going to see some of the difference coming from.
Cancer sector stakeholder in consultation
Translating equity ambitions into measurable outcomes requires sustained investment in data infrastructure.
Cancer sector stakeholder in survey
We need to be joining up at least national if not international datasets.
Cancer sector stakeholder in consultation
The dollars and the data will drive the work.
Aboriginal and Torres Strait Islander stakeholder in consultation

Enhance data infrastructure

Data and measurement were consistently identified as both a core system constraint (System-level barriers - Implementation barriers and enablers (KEQ3)) and a future opportunity. Stakeholders highlighted that limitations in data linkage, accessibility, and comparability constrain the ability to monitor progress, demonstrate impact, close equity gaps, and support continuous improvement across the cancer system.

Opportunities identified by stakeholders included strengthening national data linkage and integration, further developing and operationalising the Data Framework (including associated infrastructure investment), and improving the timeliness, accessibility, and usability of data for decision-making. Strengthened data systems were described as foundational to monitoring, evaluation, accountability, and system-wide learning.

We need data that drives change, not just reporting.
Cancer sector stakeholder in survey
We need data that drives change, not just reporting.
Cancer sector stakeholder in survey
The number one is shared data. Once someone solves that — national PROMs and PREMs, a single digit patient record — that's where I think we're going to see some of the difference coming from.
Cancer sector stakeholder in consultation
Translating equity ambitions into measurable outcomes requires sustained investment in data infrastructure.
Cancer sector stakeholder in survey
We need to be joining up at least national if not international datasets.
Cancer sector stakeholder in consultation
The dollars and the data will drive the work.
Aboriginal and Torres Strait Islander stakeholder in consultation

Strengthen implementation supports and knowledge translation

Stakeholders identified a consistent gap between strategic intent and practical implementation capability, particularly at the service level, where national frameworks and priorities have not yet been sufficiently supported by the tools, guidance, and knowledge-sharing mechanisms needed to translate them into frontline practice (Box 24).

Opportunities identified by stakeholders included providing practical implementation supports (such as strengthening and extending the Implementation Partnership model), enhancing knowledge brokerage and shared learning across organisations, sectors, and jurisdictions, and supporting the translation of evidence into service-level practice. The ACCN is an existing platform designed for this purpose that warrants further activation and broader sector awareness. Cancer Australia was identified as well-placed to play a stronger information brokering and coordination role across the system.

Plans can be a little bit theoretical — the challenge is getting them to be lived and real and embedded. To get strategy to be lived and real and embedded is a continuous effort.
Cancer sector stakeholder in consultation
Plans can be a little bit theoretical — the challenge is getting them to be lived and real and embedded. To get strategy to be lived and real and embedded is a continuous effort.
Cancer sector stakeholder in consultation
Rather than me ringing the Cancer Institute in NSW all the time, is there a way for Cancer Australia to be an information broker — particularly for small jurisdictions and organisations — to share best practice and connect people working on the same issues?
Cancer sector stakeholder in consultation
Making sure that we have the right people in the room — that probably means more engagement with clinicians. It's very easy when you are not on the ground to talk about what would work and what doesn't. Unless we create systems of care that are actually going to fit within our existing health services, it's not going to work.
Cancer sector stakeholder in consultation
Frameworks don't save lives. Implementation does.
Consumer (person affected by cancer) in consultation
Implementation of the frameworks needs to appear in the next iteration — we can do more on coordination, investment, lobbying and the efficacy piece.
Cancer sector stakeholder in consultation

Strengthen workforce capacity and models of care

As noted in Risks and unintended consequences (KEQ4), workforce capacity is a significant system constraint and an equally significant opportunity. Stakeholders identified targeted investment in workforce pipelines — including nursing, allied health, and Aboriginal and Torres Strait Islander cancer care roles — culturally safe training, Aboriginal and Torres Strait Islander leadership pathways, and models of care as priorities for the next phase of the Plan, describing workforce capability as a prerequisite for scaling and sustaining implementation, particularly in regional, rural, remote, and Aboriginal and Torres Strait Islander community settings.

Workforce investment was also identified as an area where targeted action could deliver relatively rapid and visible improvements in frontline care. The analysis of activities undertaken to date highlights an opportunity to strengthen focus on Strategic Objective 5, with comparatively lower levels of activity in workforce planning and sustainability.

Focusing on the workforce I think is really important — because without the workforce we can't deliver all of the other things in the plan.
Cancer sector stakeholder in consultation
Focusing on the workforce I think is really important — because without the workforce we can't deliver all of the other things in the plan.
Cancer sector stakeholder in consultation
Frankly, I'm not sure if it's solvable in three to five or even 10 years, but there's plenty of room for work in that pillar — and we have to think really carefully about the cancer care workforce and the way that care is delivered, particularly in remote Indigenous communities.
Cancer sector stakeholder in consultation
There are a lot more conversations now being had about our Aboriginal and Torres Strait Islander workforce being a key component within a patient's cancer journey — knowing that patient through their whole journey, and having the workforce at each stage of that journey.
Aboriginal and Torres Strait Islander stakeholder in consultation
This is about supporting the next generation of First Nations leaders who are going to drive impact in delivering better outcomes for our mobs at an individual and community level.
Aboriginal and Torres Strait Islander stakeholder in consultation

Deepening impact

Building on the elevation of equity as a system-wide priority identified in Implementation barriers and enablers (KEQ3), stakeholders emphasised the need to move equity from a policy principle to a measurable and resourced component of system performance. Stakeholders called for greater specificity, accountability, and investment, including strengthening equity-specific indicators and reporting, embedding equity in funding and service design, and ensuring accountability for equity outcomes is shared across the system rather than falling disproportionately on Aboriginal and Torres Strait Islander organisations.

This includes ensuring equity outcomes are clearly articulated and defined on appropriate terms – including what equity means in practice for Aboriginal and Torres Strait Islander peoples – and recognising that priority population frameworks do not always capture the complexity faced by people, particularly when experiencing multiple and compounding forms of disadvantage.

Stakeholders also identified opportunities to expand and deepen the equity focus - including continued prioritisation of Aboriginal and Torres Strait Islander outcomes, greater attention to rural and remote and CALD communities, rare, less common, and advanced cancers, financial toxicity, and access to supportive care and psychosocial services.

Where you live still determines whether you live.
Consumer (person affected by cancer) in consultation
Where you live still determines whether you live.
Consumer (person affected by cancer) in consultation
Screening participation gaps for Aboriginal and Torres Strait Islander people, persistent geographic inequities and inconsistent cultural safety processes are longstanding challenges the Plan was designed to address. The 2-year mark is an appropriate moment to assess honestly whether current approaches are producing the change the Plan envisages.
Cancer sector stakeholder in survey
We haven’t yet articulated the outcomes...it might be that an Indigenous elder, actually the outcome for them if they've got cancer is to die with respect and dignity on Country. It's a question of how we define equity, on whose basis, and then how we're going to follow that through.
Cancer sector stakeholder in consultation
It makes absolute sense that priority populations were socially stratified — I just think there's more to it when it comes to cancer. It is a little bit more complex than those 10 priority populations when you overlay that with certain types of cancer.
Cancer sector stakeholder in consultation
I would really like to see how others — not just those already committed — are taking this as part of their challenge. That's probably one thing I think is important for the Australian Cancer Plan to consider.
Aboriginal and Torres Strait Islander sector stakeholder in consultation

Operationalise and expand the equity focus

Building on the elevation of equity as a system-wide priority identified in Implementation barriers and enablers (KEQ3), stakeholders emphasised the need to move equity from a policy principle to a measurable and resourced component of system performance. Stakeholders called for greater specificity, accountability, and investment, including strengthening equity-specific indicators and reporting, embedding equity in funding and service design, and ensuring accountability for equity outcomes is shared across the system rather than falling disproportionately on Aboriginal and Torres Strait Islander organisations.

This includes ensuring equity outcomes are clearly articulated and defined on appropriate terms – including what equity means in practice for Aboriginal and Torres Strait Islander peoples – and recognising that priority population frameworks do not always capture the complexity faced by people, particularly when experiencing multiple and compounding forms of disadvantage.

Stakeholders also identified opportunities to expand and deepen the equity focus - including continued prioritisation of Aboriginal and Torres Strait Islander outcomes, greater attention to rural and remote and CALD communities, rare, less common, and advanced cancers, financial toxicity, and access to supportive care and psychosocial services.

Where you live still determines whether you live.
Consumer (person affected by cancer) in consultation
Where you live still determines whether you live.
Consumer (person affected by cancer) in consultation
Screening participation gaps for Aboriginal and Torres Strait Islander people, persistent geographic inequities and inconsistent cultural safety processes are longstanding challenges the Plan was designed to address. The 2-year mark is an appropriate moment to assess honestly whether current approaches are producing the change the Plan envisages.
Cancer sector stakeholder in survey
We haven’t yet articulated the outcomes...it might be that an Indigenous elder, actually the outcome for them if they've got cancer is to die with respect and dignity on Country. It's a question of how we define equity, on whose basis, and then how we're going to follow that through.
Cancer sector stakeholder in consultation
It makes absolute sense that priority populations were socially stratified — I just think there's more to it when it comes to cancer. It is a little bit more complex than those 10 priority populations when you overlay that with certain types of cancer.
Cancer sector stakeholder in consultation
I would really like to see how others — not just those already committed — are taking this as part of their challenge. That's probably one thing I think is important for the Australian Cancer Plan to consider.
Aboriginal and Torres Strait Islander sector stakeholder in consultation

Embed consumer voice and strengthen communication

As noted in Implementation barriers and enablers (KEQ3), consumers report the least visible change of any stakeholder group. While the Plan has given some consumers language and confidence to advocate for their care, stakeholders consistently identified stronger embedding of lived experience — not only in policy and advisory processes, but also in care design, multidisciplinary teams, service delivery, and evaluation — as a priority for the next phase of implementation. This includes reaching beyond existing networks and informed consumers to engage people with lived experience across diverse settings, cancer types, and communities — including those who are not already connected to Cancer Australia or the broader cancer sector.

Consumers emphasised the need to “get out of the bubble” and engage beyond established stakeholder groups, ensuring that consumer voice reflects the full diversity of those the Plan serves rather than those already at the table.

Clearer public-facing communication of the Plan and greater visibility of implementation progress were also identified as opportunities to strengthen accountability, build trust, and maintain the Plan’s relevance and credibility for those it ultimately serves.

The Plan has given patients language to ask for what they deserve.
Consumer (person affected by cancer) in consultation
The Plan has given patients language to ask for what they deserve.
Consumer (person affected by cancer) in consultation
Why aren't lived experience consumers part of multidisciplinary teams?
Consumer (person affected by cancer) in consultation
Make advocates out of the community, not just the people already in the room.
Consumer (person affected by cancer) in consultation
There's an overarching communications piece around progress on the plan — I think that communications piece is pretty, pretty important. It's a way of people not sort of forgetting about the plan until some report comes out.
Cancer sector stakeholder in consultation

Ensure adaptability and forward-looking system design

Stakeholders highlighted the importance of maintaining responsiveness to emerging evidence, new technologies, workforce pressures, and evolving population needs over the Plan's 10-year horizon. The pace of change in cancer treatment, genomics, and digital health was consistently identified as requiring an approach that is dynamic rather than static, with stakeholders specifically noting the risk of falling behind in fast-moving fields such as precision medicine if adaptive mechanisms are not in place.

Stakeholders identified the opportunity for the Plan to operate as a living framework, with built-in mechanisms for horizon scanning, periodic review, and adaptive planning to ensure the Plan and broader cancer system remain current and responsive over time. This is consistent with the Plan’s original future-focused design intent - the 10-year actions are to be codesigned with the sector and developed at an appropriate point in time, providing a structured opportunity to adapt to the evolving cancer control environment.

Variation across stakeholder groups

While there is strong agreement on the key areas for change and strengthening, stakeholder groups differ in emphasis. Policy and system actors prioritise coordination, role clarity, and system architecture. Service providers and NGOs emphasise practical implementation tools, funding certainty, and clearer delivery expectations. Aboriginal and Torres Strait Islander stakeholders focus on structural reform to ensure equity commitments are delivered in practice, sustained resourcing, and accountability. Consumers prioritise visible impact, faster progress, and stronger recognition of equity-related outcomes. Together, these perspectives reinforce the need for an approach that strengthens implementation capacity while maintaining a clear and visible focus on outcomes, equity, and lived experience.

The world and the cancer world is changing all the time - there's new developments, new treatments, new everything. How is it being responsive to that? What's the process to think about the future, and how do we keep improving and being aware?
Cancer sector stakeholder in consultation
The world and the cancer world is changing all the time - there's new developments, new treatments, new everything. How is it being responsive to that? What's the process to think about the future, and how do we keep improving and being aware?
Cancer sector stakeholder in consultation
It may be appropriate to do a deep dive and horizon scan to see if any of the priorities need to pivot, as new issues may have emerged in the time since the plan was conceived.
Cancer sector stakeholder in survey
As good as we are now with finding what's the driver of cancer, we still don't have most of the drugs that we need to actually treat the children — the full opportunity of precision medicine hasn't been realised yet.
Cancer sector stakeholder in consultation
Australia is seen as a great place for industry to do trials — there's a tsunami of work coming. I think there are some real opportunities for us as a country to invest in research to take advantage of those opportunities.
Cancer sector stakeholder in consultation
Keep going, but be prepared to adapt when necessary.
Cancer sector stakeholder in survey